Fund info

WELS invests in stocks. The fund's major sectors are Health Technology, with 87.64% stocks, and Health Services, with 7.77% of the basket. The assets are mostly located in the North America region.

WELS top holdings are Eli Lilly and Company and AbbVie, Inc., occupying 12.48% and 8.80% of the portfolio correspondingly.

WELS assets under management is ‪1.02 B‬ EUR. It's risen 79.60% over the last month.

WELS fund flows account for ‪727.92 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

WELS shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Sep 20, 2022, and its management style is Passive.

WELS expense ratio is 0.25% meaning you'd have to pay 0.25% of your investment to help manage the fund.

WELS invests in stocks.

WELS price has fallen by −1.47% over the last month, and its yearly performance shows a 10.65% increase. See more dynamics on WELS price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.29% over the last month, have fallen by −0.29% over the last month, showed a 0.66% increase in three-month performance and has increased by 11.51% in a year.